🟢 Marker Therapeutics is trading 5% up today with no clear company-specific catalyst identified

Marker Therapeutics is trading at $1.24, up 5.05%, with no clear company-specific announcement dated September 8, 2026 identified.

• The company’s official release page lists March 18, 2026, as its latest 2026 release.
• A prior H.C. Wainwright Buy rating and $10 price target was reiterated on August 21, 2026, but this is not a new September 8 catalyst.
• Broader indexes are modestly lower, so market sentiment does not clearly explain the gain.